CRP and cancer: In the present study C-reactive protein concentrations, at the time of quality of life assessment, were available in 94 patients (57 patients <10 mg l−1, 37 patients >10 mg l−1) and were significantly associated with poorer cancer-specific survival (P<0.0001).